EMA looks in­to fal­si­fied Ozem­pic with Ger­man and Aus­tri­an ori­gins

The Eu­ro­pean Med­i­cines Agency has been no­ti­fied by rel­e­vant na­tion­al au­thor­i­ties that pre-filled pens false­ly la­beled as the type 1 di­a­betes med­i­cine Ozem­pic have been iden­ti­fied at whole­salers in the EU and the UK.

The fal­si­fied pens have la­bels in Ger­man and orig­i­nat­ed from whole­salers in Aus­tria and Ger­many, the EMA said Wednes­day.

“There is no ev­i­dence that any fal­si­fied pens have been dis­pensed to pa­tients from le­gal phar­ma­cies, and there are no re­ports of harm to pa­tients in re­la­tion to the fal­si­fied med­i­cine,” EMA said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER